459 related articles for article (PubMed ID: 34332437)
1. Thrombocytopenia after COVID-19 vaccination.
Kragholm K; Sessa M; Mulvad T; Andersen MP; Collatz-Christensen H; Blomberg SN; Lippert F; Mikkelsen S; Leutscher P; Melgaard D; Torp-Pedersen C; Kristensen SR; Larsen TB; Sogaard P
J Autoimmun; 2021 Sep; 123():102712. PubMed ID: 34332437
[No Abstract] [Full Text] [Related]
2. Myocarditis after vaccination against covid-19.
Gellad WF
BMJ; 2021 Dec; 375():n3090. PubMed ID: 34916217
[No Abstract] [Full Text] [Related]
3. COVID-19 Vaccines and Thrombosis-Roadblock or Dead-End Street?
Lundstrom K; Barh D; Uhal BD; Takayama K; Aljabali AAA; Abd El-Aziz TM; Lal A; Redwan EM; Adadi P; Chauhan G; Sherchan SP; Azad GK; Rezaei N; Serrano-Aroca Á; Bazan NG; Hassan SS; Panda PK; Pal Choudhury P; Pizzol D; Kandimalla R; Baetas-da-Cruz W; Mishra YK; Palu G; Brufsky AM; Tambuwala MM; Uversky VN
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356644
[TBL] [Abstract][Full Text] [Related]
4. Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older.
Simone A; Herald J; Chen A; Gulati N; Shen AY; Lewin B; Lee MS
JAMA Intern Med; 2021 Dec; 181(12):1668-1670. PubMed ID: 34605853
[TBL] [Abstract][Full Text] [Related]
5. Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data.
Cari L; Fiore P; Naghavi Alhosseini M; Sava G; Nocentini G
J Autoimmun; 2021 Aug; 122():102685. PubMed ID: 34174723
[TBL] [Abstract][Full Text] [Related]
6. Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature.
Gardellini A; Guidotti F; Maino E; Steffanoni S; Zancanella M; Turrini M
Blood Cells Mol Dis; 2021 Dec; 92():102615. PubMed ID: 34653943
[No Abstract] [Full Text] [Related]
7. Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways.
Kircheis R
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639132
[TBL] [Abstract][Full Text] [Related]
8. Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia.
Crickx E; Moulis G; Ebbo M; Terriou L; Briantais A; Languille L; Limal N; Guillet S; Michel M; Mahevas M; Godeau B
Br J Haematol; 2021 Dec; 195(5):703-705. PubMed ID: 34467525
[No Abstract] [Full Text] [Related]
9. Age-Stratified Risk of Cerebral Venous Sinus Thrombosis After SARS-CoV-2 Vaccination.
Krzywicka K; van de Munckhof A; Sánchez van Kammen M; Heldner MR; Jood K; Lindgren E; Tatlisumak T; Putaala J; Kremer Hovinga JA; Middeldorp S; Levi MM; Cordonnier C; Arnold M; Zwinderman AH; Ferro JM; Coutinho JM; Aguiar de Sousa D
Neurology; 2022 Feb; 98(7):e759-e768. PubMed ID: 34921101
[TBL] [Abstract][Full Text] [Related]
10. Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19).
Paulsen FO; Schaefers C; Langer F; Frenzel C; Wenzel U; Hengel FE; Bokemeyer C; Seidel C
Blood; 2021 Sep; 138(11):996-999. PubMed ID: 34297792
[No Abstract] [Full Text] [Related]
11. Association of AZD1222 and BNT162b2 COVID-19 Vaccination With Thromboembolic and Thrombocytopenic Events in Frontline Personnel : A Retrospective Cohort Study.
Hviid A; Hansen JV; Thiesson EM; Wohlfahrt J
Ann Intern Med; 2022 Apr; 175(4):541-546. PubMed ID: 35103482
[TBL] [Abstract][Full Text] [Related]
12. Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial.
Madhavan M; Ritchie AJ; Aboagye J; Jenkin D; Provstgaad-Morys S; Tarbet I; Woods D; Davies S; Baker M; Platt A; Flaxman A; Smith H; Belij-Rammerstorfer S; Wilkins D; Kelly EJ; Villafana T; Green JA; Poulton I; Lambe T; Hill AVS; Ewer KJ; Douglas AD
EBioMedicine; 2022 Nov; 85():104298. PubMed ID: 36229342
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data.
Cari L; Alhosseini MN; Fiore P; Pierno S; Pacor S; Bergamo A; Sava G; Nocentini G
J Autoimmun; 2021 Dec; 125():102742. PubMed ID: 34710832
[TBL] [Abstract][Full Text] [Related]
14. Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency.
Krzywicka K; Heldner MR; Sánchez van Kammen M; van Haaps T; Hiltunen S; Silvis SM; Levi M; Kremer Hovinga JA; Jood K; Lindgren E; Tatlisumak T; Putaala J; Aguiar de Sousa D; Middeldorp S; Arnold M; Coutinho JM; Ferro JM
Eur J Neurol; 2021 Nov; 28(11):3656-3662. PubMed ID: 34293217
[TBL] [Abstract][Full Text] [Related]
15. Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry.
Bikdeli B; Jiménez D; Demelo-Rodriguez P; Galeano-Valle F; Porras JA; Barba R; Ay C; Malý R; Braester A; Imbalzano E; Rosa V; Lecumberri R; Siniscalchi C; Fidalgo Á; Ortiz S; Monreal M; For The Riete Investigators
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215771
[TBL] [Abstract][Full Text] [Related]
16. Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data.
Shaw RH; Stuart A; Greenland M; Liu X; Nguyen Van-Tam JS; Snape MD;
Lancet; 2021 May; 397(10289):2043-2046. PubMed ID: 33991480
[No Abstract] [Full Text] [Related]
17. Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in Catalonia, Spain.
Burn E; Roel E; Pistillo A; Fernández-Bertolín S; Aragón M; Raventós B; Reyes C; Verhamme K; Rijnbeek P; Li X; Strauss VY; Prieto-Alhambra D; Duarte-Salles T
Nat Commun; 2022 Nov; 13(1):7169. PubMed ID: 36418321
[TBL] [Abstract][Full Text] [Related]
18. Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose.
Kuhlmann C; Mayer CK; Claassen M; Maponga T; Burgers WA; Keeton R; Riou C; Sutherland AD; Suliman T; Shaw ML; Preiser W
Lancet; 2022 Feb; 399(10325):625-626. PubMed ID: 35063123
[No Abstract] [Full Text] [Related]
19. Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries.
Dag Berild J; Bergstad Larsen V; Myrup Thiesson E; Lehtonen T; Grøsland M; Helgeland J; Wolhlfahrt J; Vinsløv Hansen J; Palmu AA; Hviid A
JAMA Netw Open; 2022 Jun; 5(6):e2217375. PubMed ID: 35699955
[TBL] [Abstract][Full Text] [Related]
20. Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2.
Tenbusch M; Schumacher S; Vogel E; Priller A; Held J; Steininger P; Beileke S; Irrgang P; Brockhoff R; Salmanton-García J; Tinnefeld K; Mijocevic H; Schober K; Bogdan C; Yazici S; Knolle P; Cornely OA; Überla K; Protzer U;
Lancet Infect Dis; 2021 Sep; 21(9):1212-1213. PubMed ID: 34332707
[No Abstract] [Full Text] [Related]
[Next] [New Search]
